New US FDA program to help determine if device trials will lead to market approval
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is inviting feedback on its plans to create a new voluntary process that would allow device trial sponsors to determine whether their pivotal study design would support a marketing application if it is successfully executed and meets its stated endpoints without raising unforeseen safety concerns1,2.